Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Prostate Cancer

  Free Subscription


12.08.2024

2 BJU Int
1 BMC Cancer
1 BMC Urol
1 Br J Cancer
2 Cancer
1 Cancer Imaging
1 Clin Cancer Res
2 Eur Urol
1 J Natl Cancer Inst
1 J Nucl Med
7 J Urol
1 Nat Rev Urol
1 Oncogene
1 PLoS One
1 Proc Natl Acad Sci U S A
3 Prostate
2 Radiology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BJU Int

  1. BRANT A, Campi R, Carrion DM, Esperto F, et al
    Findings from an international survey of urology trainee experience with prostate biopsy.
    BJU Int. 2023;131:705-711.
    PubMed         Abstract available

  2. GEBOERS B, Scheltema MJ, Jung J, Bakker J, et al
    Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO study.
    BJU Int. 2024 Aug 5. doi: 10.1111/bju.16496.
    PubMed         Abstract available


    BMC Cancer

  3. WANG Q, Ketteler S, Bagheri S, Ebrahimifard A, et al
    Diagnostic efficacy of [(99m)Tc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis.
    BMC Cancer. 2024;24:982.
    PubMed         Abstract available


    BMC Urol

  4. JADERLING F, Bergman M, Engel JC, Mortezavi A, et al
    Tailoring biopsy strategy in the MRI-fusion prostate biopsy era: systematic, targeted or neither?
    BMC Urol. 2024;24:168.
    PubMed         Abstract available


    Br J Cancer

  5. RAHMAN R, Rahaman MH, Hanson AR, Choo N, et al
    CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.
    Br J Cancer. 2024 Aug 8. doi: 10.1038/s41416-024-02810.
    PubMed         Abstract available


    Cancer


  6. Addition of apalutamide to ADT after radical prostatectomy offers encouraging results.
    Cancer. 2024;130:2896.
    PubMed        

  7. NIERENGARTEN MB
    Optimal timing of radiotherapy after radical prostatectomy points to salvage radiotherapy for PSA failure.
    Cancer. 2024;130:2895.
    PubMed        


    Cancer Imaging

  8. XU L, Peng Q, Zhang G, Zhang D, et al
    Development of preoperative nomograms to predict the risk of overall and multifocal positive surgical margin after radical prostatectomy.
    Cancer Imaging. 2024;24:104.
    PubMed         Abstract available


    Clin Cancer Res

  9. HUSSAIN M, Kocherginsky M, Agarwal N, Adra N, et al
    Abiraterone, Olaparib, or Abiraterone + Olaparib in First-line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway).
    Clin Cancer Res. 2024 Aug 8. doi: 10.1158/1078-0432.CCR-24-1402.
    PubMed         Abstract available


    Eur Urol

  10. GORADIA R, Abdollah F, Sood A
    Re: Integrative Multi-Region Molecular Profiling of Primary Prostate Cancer in Men with Synchronous Lymph Node Metastasis.
    Eur Urol. 2024 Aug 6:S0302-2838(24)02497-7. doi: 10.1016/j.eururo.2024.
    PubMed        

  11. KAMRAN SC, Efstathiou JA
    Honing Stratification and Treatment for High-risk Prostate Cancer.
    Eur Urol. 2024 Aug 6:S0302-2838(24)02489-8. doi: 10.1016/j.eururo.2024.
    PubMed        


    J Natl Cancer Inst

  12. KATKI HA, Prorok PC, Castle PE, Minasian LM, et al
    Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening.
    J Natl Cancer Inst. 2024;116:1280-1287.
    PubMed         Abstract available


    J Nucl Med

  13. MAINTA IC, Neroladaki A, Wolf NB, Benamran D, et al
    [(68)Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria.
    J Nucl Med. 2024 Aug 8:jnumed.124.267899. doi: 10.2967/jnumed.124.267899.
    PubMed         Abstract available


    J Urol

  14. SINGHAL U, Hollenbeck BK, Kaffenberger SD, Salami SS, et al
    Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.
    J Urol. 2023;210:771-777.
    PubMed         Abstract available

  15. ZILLIOUX J, Camacho FT, Anderson RT, You W, et al
    Prevalence of Cognitive and Manual Dexterity Disorders Among Men Following Artificial Urinary Sphincter Placement.
    J Urol. 2024;212:441-450.
    PubMed         Abstract available

  16. DROGHETTI M, Ozman O, Berrens AC, Piazza P, et al
    Location-Based Oncological Outcomes of Sentinel Node Dissection in Radical Prostatectomy.
    J Urol. 2024;212:409-419.
    PubMed         Abstract available

  17. MIAN BM, Kaufman RP Jr, Berstein A, Fisher HAG, et al
    Letter: Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial.
    J Urol. 2024;212:511-512.
    PubMed        

  18. KLOTZ L
    The Genomics and Natural History of MRI-Visible vs MRI-Invisible Prostate Cancers: Clinical Implications.
    J Urol. 2024;212:494-498.
    PubMed        

  19. GAFFNEY CD, Vertosick EA, Laudone V, Goh AC, et al
    Randomized Trial of Transverse vs Vertical Extraction Site Incision After Robotic Radical Prostatectomy.
    J Urol. 2024;212:401-408.
    PubMed         Abstract available

  20. SHORE N, Pieczonka C, Heron S, Gazi M, et al
    Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer.
    J Urol. 2024 Aug 9:101097JU0000000000004190. doi: 10.1097/JU.0000000000004190.
    PubMed         Abstract available


    Nat Rev Urol

  21. EAPEN RS, Williams SG, Macdonald S, Keam SP, et al
    Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer.
    Nat Rev Urol. 2024 Aug 7. doi: 10.1038/s41585-024-00913.
    PubMed         Abstract available


    Oncogene

  22. XIONG S, Li S, Li Z, Song Y, et al
    A noncanonical E3 ubiquitin ligase RNF41-mediated MYO1C stability promotes prostate cancer metastasis by inducing actin remodeling.
    Oncogene. 2024 Aug 7. doi: 10.1038/s41388-024-03120.
    PubMed         Abstract available


    PLoS One

  23. HUANG PC, Huang LH, Yang CK, Li JR, et al
    Comparative analysis of novel hormonal agents in non-metastatic castration-resistant prostate cancer: A Taiwanese perspective.
    PLoS One. 2024;19:e0306900.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  24. YU G, Corn PG, Mak CSL, Liang X, et al
    Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization.
    Proc Natl Acad Sci U S A. 2024;121:e2402903121.
    PubMed         Abstract available


    Prostate

  25. WANG H, He K, Liu Y, Yang L, et al
    Expression and immune infiltration studies of IL-33-ST2-NF-kappaB signaling pathway in prostate cancer.
    Prostate. 2024 Aug 7. doi: 10.1002/pros.24778.
    PubMed         Abstract available

  26. WAKAMORI C, De Velasco MA, Sakai K, Kura Y, et al
    A cross-species analysis of fecal microbiomes in humans and mice reveals similarities and dissimilarities associated with prostate cancer risk.
    Prostate. 2024 Aug 7. doi: 10.1002/pros.24776.
    PubMed         Abstract available

  27. ONAL C, Guler OC, Torun N, Elmali A, et al
    Impact of definitive radiotherapy on metabolic response measured with (68)Ga-PSMA-PET/CT in patients with intermediate-risk prostate cancer.
    Prostate. 2024 Aug 6. doi: 10.1002/pros.24775.
    PubMed         Abstract available


    Radiology

  28. JOHNSON PM, Chandarana H
    AI-powered Diagnostics: Transforming Prostate Cancer Diagnosis with MRI.
    Radiology. 2024;312:e241009.
    PubMed        

  29. CAI JC, Nakai H, Kuanar S, Froemming AT, et al
    Fully Automated Deep Learning Model to Detect Clinically Significant Prostate Cancer at MRI.
    Radiology. 2024;312:e232635.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.